NCT01659866View on ClinicalTrials.gov

Antibiotic Prophylaxis for Transrectal Prostate Biopsy

PHASE4CompletedINTERVENTIONAL
Enrollment

563

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2016

Conditions
Infection
Interventions
DRUG

Ciprofloxacin

500 mg orally 2 hours before prostate biopsy

DRUG

trimethoprim-sulfamethoxazole

1 double strength tablet orally 2 hours before the procedure and again 12 hours later

DRUG

cefuroxime

500 mg orally 2 hours before the procedure then again 12 hours later

DRUG

ceftriaxone

500 mg intramuscularly 2 hours before the procedure

DRUG

gentamicin

2 mg/kg intramuscularly 2 hours before the procedure

DRUG

amikacin

5 mg/kg intramuscularly 2 hours before the procedure

DRUG

aztreonam

500 mg intramuscularly 2 hours before the procedure

DRUG

imipenem

500 mg intramuscularly 2 hours before the procedure

DRUG

ceftriaxone

2000 mg intravenously 1 hour before the procedure

DRUG

gentamicin

2 mg/kg intravenously 1 hour before the procedure

DRUG

amikacin

5 mg/kg intravenously 1 hour before the procedure

DRUG

aztreonam

2000 mg intravenously 1 hour before the procedure

DRUG

imipenem

1000 mg intravenously 1 hour before the procedure

Trial Locations (1)

60611

Northwestern University Department of Urology, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT01659866 - Antibiotic Prophylaxis for Transrectal Prostate Biopsy | Biotech Hunter | Biotech Hunter